Clinical Trial Update: Safety and Efficacy Study of the DANUBIO Paclitaxel Eluting Balloon in In-Stent Restenosis Lesions (DEBREST) [NA]

View source ↗

Summary

A completed safety and efficacy study evaluating the DANUBIO Paclitaxel Eluting Balloon for in-stent restenosis lesions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• In-stent Restenosis

Drugs mentioned

• DANUBIO Paclitaxel Eluting Balloon (paclitaxel-eluting balloon)

Snippet

Sponsor: MINVASYS | Conditions: In-stent Coronary Artery Restenosis | NA | Status: COMPLETED